Kidswell Bio Corporation
4584.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥5 | ¥5 | ¥8 | ¥14 |
| - Cash | ¥3 | ¥2 | ¥1 | ¥1 |
| + Debt | ¥2 | ¥3 | ¥2 | ¥1 |
| Enterprise Value | ¥3 | ¥5 | ¥9 | ¥14 |
| Revenue | ¥5 | ¥2 | ¥3 | ¥2 |
| % Growth | 109% | -12.4% | 76.9% | – |
| Gross Profit | ¥2 | ¥1 | ¥2 | ¥1 |
| % Margin | 32.3% | 42.8% | 55% | 64.9% |
| EBITDA | ¥0 | -¥1 | -¥1 | -¥1 |
| % Margin | 2.3% | -56.8% | -22.3% | -33.9% |
| Net Income | -¥0 | -¥1 | -¥1 | -¥1 |
| % Margin | -0.4% | -58.5% | -23.7% | -35.1% |
| EPS Diluted | -0.52 | -40.23 | -20.77 | -17.86 |
| % Growth | 98.7% | -93.7% | -16.3% | – |
| Operating Cash Flow | ¥1 | -¥0 | -¥1 | -¥1 |
| Capital Expenditures | -¥0 | ¥0 | ¥1 | -¥0 |
| Free Cash Flow | ¥1 | -¥0 | -¥1 | -¥1 |